GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (LSE:REDX) » Definitions » Equity-to-Asset

Redx Pharma (LSE:REDX) Equity-to-Asset : 0.13 (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Redx Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Redx Pharma's Total Stockholders Equity for the quarter that ended in Sep. 2023 was £3.36 Mil. Redx Pharma's Total Assets for the quarter that ended in Sep. 2023 was £25.64 Mil. Therefore, Redx Pharma's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.13.

The historical rank and industry rank for Redx Pharma's Equity-to-Asset or its related term are showing as below:

LSE:REDX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06   Med: 0.3   Max: 0.56
Current: 0.13

During the past 12 years, the highest Equity to Asset Ratio of Redx Pharma was 0.56. The lowest was 0.06. And the median was 0.30.

LSE:REDX's Equity-to-Asset is ranked worse than
81.88% of 1562 companies
in the Biotechnology industry
Industry Median: 0.67 vs LSE:REDX: 0.13

Redx Pharma Equity-to-Asset Historical Data

The historical data trend for Redx Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma Equity-to-Asset Chart

Redx Pharma Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.06 0.33 0.53 0.13

Redx Pharma Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.14 0.53 0.35 0.13

Competitive Comparison of Redx Pharma's Equity-to-Asset

For the Biotechnology subindustry, Redx Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redx Pharma's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Redx Pharma's Equity-to-Asset falls into.



Redx Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Redx Pharma's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Equity to Asset (A: Sep. 2023 )=Total Stockholders Equity/Total Assets
=3.355/25.636
=0.13

Redx Pharma's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=3.355/25.636
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Redx Pharma  (LSE:REDX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Redx Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Redx Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Redx Pharma (LSE:REDX) Business Description

Traded in Other Exchanges
N/A
Address
Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (LSE:REDX) Headlines

No Headlines